CSS »

Apellis Pharmaceuticals shares owned by CSS

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by CSS from 13F filings

Historical chart of CSS investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by CSS consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by CSS

Quarter filed Position value Share count Share price at filing
2026-03-31 $5.1M 127k 40.23
2022-09-30 $1.9M 28k 68.24
2022-03-31 $2.3M 45k 50.48
2020-03-31 $309k 12k 26.89
2019-12-31 $1.4M 45k 30.62

More positions owned by CSS

Lumentum Hldgs Note 0.500% 6/1 (Principal)
Echostar Corp Note 3.875%11/3 (Principal)
Jazz Investments I Note 2.000% 6/1 (Principal)
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
Transocean Deb 4.625% 9/3 (Principal)
Peabody Engr Corp Note 3.250% 3/0 (Principal)
Gamestop Corp Cl A (GME)
Nextera Energy Unit 02/15/2029 (NEE.PV)
Centerpoint Energy Note 4.250% 8/1 (Principal)
Penumbra (PEN)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)
Hologic
Spdr Gold Tr Gold Shs (GLD)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for CSS

Top funds holding Apellis Pharmaceuticals

BlackRock
Wellington Management Company
venBio Select Advisor
Vanguard Group
Morgan Stanley
Rtw Investments
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
State Street Corporation
Deep Track Capital
Point72 Asset Management
Polar Capital Holdings
HBK Investments

View all funds holding Apellis Pharmaceuticals